Tyrosine kinase inhibitor
CAS No. 1021950-26-4
Tyrosine kinase inhibitor ( —— )
产品货号. M26856 CAS No. 1021950-26-4
酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2863 | 有现货 |
|
| 10MG | ¥3859 | 有现货 |
|
| 25MG | ¥4932 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Tyrosine kinase inhibitor
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
-
产品描述Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.(In Vitro):Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics.
-
体外实验Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli.
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点c-Met/HGFR
-
受体Reactive Oxygen Species
-
研究领域——
-
适应症——
化学信息
-
CAS Number1021950-26-4
-
分子量586.624
-
分子式C31H31FN6O5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 46 mg/mL (78.42 mM)
-
SMILESFc1ccc(NC(=O)C2(CC2)C(=O)Nc2ccc(Oc3ccnc4[nH]c(cc34)C(=O)NCCN3CCOCC3)cc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Suparna Qanungo, et al. N-Acetyl-L-cysteine Enhances Apoptosis Through Inhibition of Nuclear factor-kappaB in Hypoxic Murine Embryonic Fibroblasts. J Biol Chem
产品手册
关联产品
-
Emibetuzumab
Emibetuzumab (LY2875358) 是一种人源化二价 MET 抗体 (IgG4 型)。Emibetuzumab 具有较高的中和与内化活性,能有效抑制 HGF 依赖性和非依赖性 MET 通路的激活和肿瘤生长。Emibetuzumab 可用于癌症的研究。
-
Rilotumumab
Rilotumumab (AMG 102) 是一种 anti-HGF (抗肝细胞生长因子) 的单克隆抗体,抑制 HGF/MET 驱动的信号传导。Rilotumumab 具有抗肿瘤活性,可用于去势抵抗性前列腺癌 (CRPC) 和实体瘤的研究。
-
PF-04217903 methanes...
PF-04217903 是一种有效、选择性、ATP 竞争性 c-Met 激酶抑制剂,Ki 为 4.8 nM。
021-51111890
购物车()
sales@molnova.cn

